HomeOwner SearchCategory Search
Design and Synthesis of Pyrimidine Based Heterocycles as Potential Anti-cancer Agents with Combination Chemotherapeutic Potential or Targeted One Carbon Metabolism Inhibition and Anti-opportunistic Agents
Visit USCO
hero image
Text Registration
Copyright Title

Design and Synthesis of Pyrimidine Based Heterocycles as Potential Anti-cancer Agents with Combination Chemotherapeutic Potential or Targeted One Carbon Metabolism Inhibition and Anti-opportunistic Agents

Status

Published

on 4 Dec 2019
Year of Creation
2019
Copyright Claimant
Arpit Bharat Doshi
Registration Number
TX0008822313
on 4 Dec 2019

Copyright Summary


The U.S. Copyright record (Registration Number: TX0008822313) dated 4 Dec 2019, pertains to an electronic file (eService) titled "Design and Synthesis of Pyrimidine Based Heterocycles as Potential Anti-cancer Agents with Combination Chemotherapeutic Potential or Targeted One Carbon Metabolism Inhibition and Anti-opportunistic Agents" created in 2019. The copyright holder is Arpit Bharat Doshi, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Arpit Bharat Doshi.

Copyright Details


Copyright Claimant
Arpit Bharat Doshi

Application Details


Registration Number
TX0008822313
Registration Date
12/4/2019
Year of Creation
2019
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic file (eService)
First Publication Nation
United States

Personal Authors


Notes


Rights Note: Mark Dill, ProQuest, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements


Application Title Statement: Design and Synthesis of Pyrimidine Based Heterocycles as Potential Anti-cancer Agents with Combination Chemotherapeutic Potential or Targeted One Carbon Metabolism Inhibition and Anti-opportunistic Agents
Author Statement: Arpit Doshi Citizenship: not known Authorship: text
Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

© 2024 reserved by Trademarkia
Show terms & conditions